Abstract
Background
Adrenal insufficiency (AI) is a life-threatening disease characterized by deficient production of glucocorticoids and/or mineralocorticoids. It is caused by primary or secondary/tertiary adrenal failure. Prompt diagnosis and management are essential and may even be life-saving.
Methods
We retrospectively collected clinical, laboratory and radiological data from AI patients observed over 34 years (1984–2017) in a pediatric endocrinology department of a tertiary care hospital.
Results
Seventy AI patients were identified: 59% with primary adrenal insufficiency (PAI) and 41% with central adrenal insufficiency (CAI). PAI patients were diagnosed at 1.5 ± 4.4 years and followed for 11.6 ± 6.2 years; 85% had classical congenital adrenal hyperplasia (CAH) and 7% had autoimmune PAI. At presentation, 73% had hyponatremia and more than half had mucocutaneous hyperpigmentation, asthenia, anorexia, weight loss, nausea and vomiting. All the patients were treated with hydrocortisone and 90% were also on fludrocortisone. Regarding CAI patients, they were diagnosed at 5.4 ± 5.0 years and they were followed for 9.6 ± 6.4 years; craniopharyngioma was present in 31% of the cases and 14% had pituitary hypoplasia. Besides corticotropin, thyrotropin (93%), growth hormone (63%) and antidiuretic hormone (52%) were the most common hormone insufficiencies. The most frequent manifestations were hypoglycemia (34.5%), nausea/vomiting (27.6%) and infectious diseases (27.6%); all the patients were treated with hydrocortisone.
Conclusions
Despite medical advances, the diagnosis and management of AI remains a challenge, particularly in the pediatric population. Raising awareness and knowledge in medical teams and population about the disease is of crucial importance to improve clinical outcomes and to reduce disease morbidity/mortality.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Hahner S, Allolio B. Management of adrenal insufficiency in different clinical settings. Expert Opin Pharmacother 2005;6:2407–17.10.1517/14656566.6.14.2407Search in Google Scholar
2. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89.10.1210/jc.2015-1710Search in Google Scholar
3. Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015;3:216–26.10.1016/S2213-8587(14)70142-1Search in Google Scholar
4. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet 2014;383:2152–67.10.1016/B0-12-475570-4/00029-9Search in Google Scholar
5. Shulman DI, Palmert MR, Kemp SF, Lawson Wilkins D, Therapeutics C. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 2007;119:e484–94.10.1542/peds.2006-1612Search in Google Scholar PubMed
6. Simm PJ, McDonnell CM, Zacharin MR. Primary adrenal insufficiency in childhood and adolescence: advances in diagnosis and management. J Paediatr Child Health 2004;40:596–9.10.1111/j.1440-1754.2004.00482.xSearch in Google Scholar PubMed
7. Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, et al. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab 2005;90:3243–50.10.1210/jc.2004-0016Search in Google Scholar PubMed
8. Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab 2011;96:E925–8.10.1210/jc.2011-0015Search in Google Scholar PubMed
9. Kirkgoz T, Guran T. Primary adrenal insufficiency in children: diagnosis and management. Best Pract Res Clin Endocrinol Metab 2018;32:397–424.10.1016/j.beem.2018.05.010Search in Google Scholar PubMed
10. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 2006;91:4849–53.10.1210/jc.2006-0076Search in Google Scholar PubMed
11. Ekman B, Fitts D, Marelli C, Murray RD, Quinkler M, et al. European adrenal insufficiency registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy. BMC Endocr Disord 2014;14:40.10.1186/1472-6823-14-40Search in Google Scholar PubMed PubMed Central
12. Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H. Adrenal crises in children: perspectives and research directions. Horm Res Paediatr 2018;89:341–51.10.1159/000481660Search in Google Scholar PubMed
13. Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015;172:R115–24.10.1530/EJE-14-0824Search in Google Scholar PubMed
14. Pezzuti IL, Barra CB, Mantovani RM, Januario JN, Silva IN. A three-year follow-up of congenital adrenal hyperplasia newborn screening. J Pediatr (Rio J) 2014;90:300–7.10.1016/j.jped.2013.09.007Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
